Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights
11:52am, Friday, 24'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Danaher Corporation (NYSE: DHR) breached their fiduciary duties to
DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
04:52pm, Thursday, 23'rd Oct 2025
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher
These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings
01:01pm, Wednesday, 22'nd Oct 2025
Danaher Corporation (NYSE:DHR) reported better-than-expected third-quarter financial results on Tuesday.
Is Danaher’s Q3 beat enough to reignite long-term growth for DHR investors?
11:30am, Wednesday, 22'nd Oct 2025
Danaher stock surged over 7% on Tuesday after the company delivered a solid third-quarter performance, with revenues rising 4.5% to $6.1 billion and non-GAAP adjusted EPS of $1.89, significantly outpa
Danaher: Regaining Growth Momentum
10:49am, Wednesday, 22'nd Oct 2025
Danaher Corporation is regaining growth momentum, with strong Q3 results, positive 2026 guidance, and robust performance in its Biotechnology segment. DHR's management maintains conservative full-year
Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment
08:10am, Wednesday, 22'nd Oct 2025
Danaher Corporation reported solid Q3/25 results with 4.4% revenue growth and improved margins, yet valuation concerns persist. Despite management's optimism for high single-digit long-term growth, Da
Danaher (NYSE:DHR) Shares Gap Up Following Earnings Beat
01:36am, Wednesday, 22'nd Oct 2025
Danaher Corporation (NYSE: DHR - Get Free Report)'s stock price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $20
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
04:45pm, Tuesday, 21'st Oct 2025
NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Co
Here's Why Shares in Danaher Got Boosted Higher Today
02:17pm, Tuesday, 21'st Oct 2025
Danaher's biotechnology growth prospects look assured. Guidance for 2026 is merely within the range of current market expectations.
Danaher Q3 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
01:41pm, Tuesday, 21'st Oct 2025
DHR Q3 earnings and sales beat estimates, driven by solid segment growth and stronger operating margins.
Danaher Tops Its 5% Chase Zone As One Key Division Drives Growth
11:42am, Tuesday, 21'st Oct 2025
Shares of Danaher surged Tuesday after the medical research company beat third-quarter forecasts on the back of its bioprocessing division.
Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript
11:14am, Tuesday, 21'st Oct 2025
Danaher Corporation (NYSE:DHR ) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT Company Participants John Bedford - Vice President of Investor Relations Rainer Blair - President, CEO & Director Mat
Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say
10:30am, Tuesday, 21'st Oct 2025
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Stre
Danaher (DHR) Q3 Earnings and Revenues Beat Estimates
08:16am, Tuesday, 21'st Oct 2025
Danaher (DHR) came out with quarterly earnings of $1.89 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.71 per share a year ago.
Danaher beats quarterly estimates on strength in diagnostic tools and tech
07:01am, Tuesday, 21'st Oct 2025
Life Sciences firm Danaher on Tuesday beat Wall Street's third-quarter profit and revenue estimates, buoyed by resilient demand for its diagnostic testing tools and services, sending its shares up 1.3
